Healthcare stocks declined Monday afternoon, with the NYSE Healthcare Index decreasing 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.5%.
The iShares Biotechnology ETF (IBB) rose 0.7%.
In corporate news, Neumora Therapeutics (NMRA) shares fell 48% after the firm said Monday it is discontinuing development of its major depressive disorder treatment navacaprant after two phase 3 trials failed to meet their primary and key secondary endpoints.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments